Cancer BiologyCancer ResearchPeer-reviewed
Exploiting De Novo Serine Synthesis as a Metabolic Vulnerability to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma
Manon Teisseire, Umakant Sahu, Julien Parola…·Sandy Giuliano
This study identifies serine synthesis as a metabolic vulnerability in sunitinib-resistant renal cell carcinoma, showing that inhibiting key enzymes enhances drug sensitivity.
13 citations